Skip to main content

NIOX Group Plc (CSSPF)

New York Stock Exchange Healthcare Medical - DevicesView data quality →
56.9Fair

ValueMarkers Composite Index

Top 66%#15,225 of 44,714

DCF data not available

Piotroski
7/9
Strong
Beneish
-2.19
Investigate
Altman
29.13
Safe
DCF Value
-
N/A
ROIC
9.8%
Adequate
P/E
34.5
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

NIOX Group Plc (CSSPF) — VMCI valuation read

The headline on NIOX Group Plc (CSSPF) is a 57/100 VMCI score, set against a Healthcare sector median of 50. That 7-point above-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value tailwind is in the data.

CSSPF insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** CSSPF trades at 19.0x earnings, 6% above the Healthcare median of 18.0x sets the value side. ROIC of 11.0% sits 1.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of -0.6x leaves covenant headroom sets the risk side, the three lines a value buyer reads first on CSSPF.

CSSPF rose 2.9% over the trailing 7 days, with a -23.5% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.